Books · podcasts · films · documentaries · videos · courses · research
One library. Every doorway.
67 verified direct links to deeper learning. Search the whole collection, choose a format, then open the original publisher, podcast, streaming service, university, public agency, or research source.
Every button below opens the original source in a new tab. Some items require purchase or a streaming subscription, and availability can vary by country. Inclusion is educational, not a medical endorsement. Personal stories and media are not clinical evidence.
67resources in the full library
Books & audiobooksPaperback, ebook, and audiobook
How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence
Michael Pollan
A reported, first-person survey of the modern revival of psychedelic research that connects laboratory science, policy history, therapist practice, and the author’s own experiences. It is best read as narrative nonfiction about an evolving field rather than as clinical guidance.
psychedelic research historypsilocybinLSDmental health
Access and content notes
Access: Paid
Discusses depression, anxiety around serious illness and dying, addiction, illegal drug use, and personal accounts of altered states.
American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century
Ido Hartogsohn
This cultural history examines how expectations, surroundings, and social forces helped shape psychedelic experiences in twentieth-century United States contexts. Its emphasis is on interpretation and historical change, not on a how-to approach to use.
research historyset and settingUS cultural historypsychedelic experience
Access and content notes
Access: Paid
Addresses illicit-drug history, social conflict, and altered-state experiences; no specific graphic-content warning is indicated on the publisher page.
Acid Dreams: The Complete Social History of LSD: The CIA, the Sixties, and Beyond
Martin A. Lee and Bruce Shlain
A social and political history of LSD that follows intersections among government experimentation, counterculture, and public backlash. It foregrounds institutions and the consequences of drug policy alongside the era’s cultural movements.
LSDCIA historycounterculturedrug policy
Access and content notes
Access: Paid
Discusses covert government drug experimentation, illicit drug use, and political repression; potentially disturbing historical material.
Singing to the Plants: A Guide to Mestizo Shamanism in the Upper Amazon
Stephan V. Beyer
An extended ethnographic account of mestizo healing traditions in the Upper Amazon, including plant-centered cosmologies and ceremonial practice. It offers cultural and religious context around ayahuasca rather than reducing those traditions to a biomedical model.
ayahuascaAmazoniamestizo shamanismethnography
Access and content notes
Access: Paid
Discusses ceremonial psychoactive-plant use, illness, death, and intense visionary experiences; readers should approach descriptions of living traditions respectfully.
The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience
Benny Shanon
A cognitive-psychological study that organizes and analyzes reported features of ayahuasca experiences. The academic treatment concentrates on phenomenology and interpretation, while also engaging anthropological and religious questions.
Access: Mixed (paid paperback; online access for subscribing libraries/institutions)
Contains detailed discussion of powerful altered states and religious/visionary imagery; no specific graphic-content warning is indicated on the publisher page.
This interdisciplinary edited volume brings biomedical, anthropological, ritual, and policy perspectives to questions about ayahuasca in therapeutic settings. It includes evidence and debate about research methods, ethics, and the limits of treatment claims across distinct cultural settings.
Discusses depression, PTSD, substance dependence, and ceremonial psychoactive use. It is academic discussion, not a substitute for medical care or treatment advice.
Psychedelic Integration: Psychotherapy for Non-Ordinary States of Consciousness
Marc B. Aixalà; foreword by José Carlos Bouso
A practitioner-oriented overview of preparation, integration, and psychotherapy frameworks for people processing non-ordinary states. It connects post-experience reflection with clinical and embodied approaches, while acknowledging that difficult experiences may require support.
integrationpsychotherapypreparationharm reduction
Access and content notes
Access: Paid
Discusses challenging psychedelic experiences, psychological distress, and therapeutic practice; it is not individualized clinical or crisis guidance.
Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture
Edited by Clancy Cavnar and Beatriz Caiuby Labate
This essay collection assesses the contemporary psychedelic field through equity, power, sustainability, cultural appropriation, and policy. It centers critiques of whose knowledge is recognized and who may bear the costs or benefits of commercialization and reform.
social justiceIndigenous perspectivescultural appropriationdrug policy
Access and content notes
Access: Paid
Discusses marginalization, racism, colonialism, sex and power, criminalization, and cultural appropriation; potentially challenging social-justice material.
Ibogaine: Proceedings from the First International Conference
Kenneth R. Alper and Geoffrey A. Cordell
Proceedings from a 1999 New York University School of Medicine conference compile early work on ibogaine’s pharmacology, clinical reports, sociocultural context, and regulation. The volume is particularly useful for locating historical questions and safety concerns that accompanied early ibogaine research.
ibogainepharmacologyaddiction researchsafety
Access and content notes
Access: Paid (availability varies by region)
Discusses opioid withdrawal, addiction, nonmedical treatment settings, neurotoxicity, and safety risks. It is a historical scholarly resource, not treatment guidance.
The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys
James Fadiman
A broad guide that combines older research, practitioner perspectives, and the author’s proposed frameworks for psychedelic experiences at different dose ranges. Its claims and practical orientation should be evaluated critically against current law, evidence, and professional standards.
psychedelic research historyLSDpsilocybinmicrodosing
Access and content notes
Access: Paid
Contains discussion of drug use, self-experimentation, challenging experiences, and medical/psychological claims; it should not be treated as medical, legal, or individualized safety advice.
A critical political-economy analysis of how investment, intellectual property, medicalization, and drug-war institutions influence the current psychedelic marketplace. The authors question whether commercialization can coexist with public interest, equitable access, and respect for Indigenous knowledge.
Discusses criminalization, inequality, corporate power, cultural appropriation, and the drug war; no specific graphic-content warning is indicated on the publisher page.
Books & audiobooksTrade paperback, ebook, and unabridged audiobook
Ibogaine and the Bicameral Mind: The Transformational Potential of the World’s Most Complex Psychedelic Medicine
Jonathan Dickinson
This contemporary account links iboga’s Bwiti ceremonial roots with case-based discussions of ibogaine, neuroscience, trauma, and addiction recovery. Because the author is also an ibogaine-clinic executive, readers should distinguish its perspective and case reports from independent clinical evidence.
ibogaineBwitiaddictiontrauma
Access and content notes
Access: Paid
Discusses addiction, PTSD, traumatic brain injury, neurological illness, psychoactive treatment claims, and intense altered states. Ibogaine carries serious safety risks, and the book is not medical advice.
PodcastsPodcast episode; VA News publisher page with audio-only show link
New Horizons in Health — Exploring psychedelics for the treatment of Veterans
U.S. Department of Veterans Affairs (VA) / Veterans Health Administration
A VA-led discussion examines research protocols for psychedelic-assisted therapies in veterans, including screening, medical monitoring, psychotherapy, and social support. It also distinguishes supervised research from self-medication and considers risks alongside the research questions.
veteransPTSDclinical researchsafety
Access and content notes
Access: Free — public VA page and linked audio-only podcast site.
Discusses PTSD, suicidal ideation, self-medication, and risks of serious injury or death outside medical care.
PodcastsNarrative podcast episode with full transcript
Altered States, Episode 10 — A Navy SEAL Goes to Mexico to Take Ibogaine
UC Berkeley Center for the Science of Psychedelics / PRX
This reported episode follows a retired combat veteran and his family as they navigate cognitive difficulties, traumatic brain injury, and a decision to seek ibogaine treatment abroad. It situates the personal account within questions about legality, access, regulation, and research involving veterans.
veteransibogainetraumatic brain injuryPTSD
Access and content notes
Access: Free — public UC Berkeley episode page and transcript; the show page links to listening options.
The publisher warns that the episode mentions suicide and suicidal ideation; it also covers combat trauma and treatment outside the United States.
PodcastsLong-form interview podcast episode with transcript
Huberman Lab — Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health
Huberman Lab; host Andrew Huberman
Andrew Huberman interviews neuroscientist Robin Carhart-Harris about research on psilocybin, LSD, and DMT, including brain change, trial design, and limits of interpretation. The conversation addresses preparation, therapist support, integration, legal context, and risks as well as proposed therapeutic mechanisms.
pharmacology and neurosciencepsilocybinLSDDMT
Access and content notes
Access: Free — public episode page with YouTube, Apple Podcasts, Spotify, and transcript links.
Discusses mental-health conditions, hallucinations, addiction, and challenging psychological experiences; no graphic-content warning is posted on the source page.
PodcastsUniversity research podcast episode with transcript
Show Me the Science — Can psychedelic drugs help treat mental illness?
Washington University School of Medicine in St. Louis
Washington University researchers discuss imaging studies of psilocybin and the gap between observed brain-network changes and clinical benefit. The episode explains the early state of evidence and describes preparation and supervised support used in research participants’ sessions.
Johns Hopkins Medicine Health Newsfeed — What is needed clinically to use psilocybin to treat depression?
Johns Hopkins Medicine; Elizabeth Tracey reporting with Matthew Johnson
This short report focuses on why a clinical psilocybin model involves preparation, monitoring, an appropriate environment, and a guide rather than simply the drug itself. It relays a researcher’s caution against unsupervised self-treatment and notes that panic or anxiety can require clinical management.
psilocybindepressionclinical settingpreparation
Access and content notes
Access: Free — public Johns Hopkins Medicine page with embedded downloadable MP3.
Discusses depression and anxiety or panic reactions during unsupervised use; no graphic-content warning is posted.
Psychedelics Today, PT408 — Fireside Project: Harm Reduction Through Free Peer Support
Psychedelics Today; host David and guests Hanifa Nayo Washington and Joshua White
The founders of Fireside Project describe a peer-support model for people during challenging psychedelic experiences and while processing them afterward. The discussion differentiates peer support from diagnosis or therapy and considers volunteer preparation, access, and nonjudgmental crisis response.
PodcastsEducational podcast episode with detailed study notes
Psychiatry & Psychotherapy Podcast, Episode 106 — Psilocybin Therapy Part 2: Clinical Trials, Secondary Effects, Brain Imaging, and the Future of Psilocybin Therapy
Psychiatry & Psychotherapy Podcast; David Puder, MD and Nadav Klein, MD
This evidence-oriented episode reviews psilocybin trial designs and findings across depression, anxiety, addiction, personality outcomes, and imaging research. It emphasizes methodological limits, including blinding challenges, and frames preparation, supervision, and integration as parts of the studied therapy model.
PodcastsUniversity neuroscience podcast episode with transcript
From Our Neurons to Yours — Psychedelics Inside Out: How do LSD and psilocybin alter perception? (Part 2)
Stanford Wu Tsai Neurosciences Institute; host Nicholas Weiler with Boris Heifets, MD, PhD
Stanford anesthesiologist and researcher Boris Heifets discusses how classical psychedelics are defined and how LSD and psilocybin may alter perception through brain circuits and chemistry. It is particularly useful for separating mechanism questions from broader claims about clinical benefit.
pharmacology and neuroscienceLSDpsilocybinperception
Access and content notes
Access: Free — public Stanford episode page with Apple Podcasts, Spotify, Amazon Music, other listening links, and transcript.
Includes descriptions of altered perception, paranoia, and mental-health research; no graphic-content warning is posted.
Neuro Pathways — Renewed Interest in Psychedelic Treatment for Behavioral Health Conditions
Cleveland Clinic; host Glen Stevens, DO, PhD with Brian Barnett, MD
Cleveland Clinic psychiatrist Brian Barnett reviews the current research landscape for psilocybin and MDMA in behavioral health, including proposed serotonin-pathway and neuroplasticity mechanisms. The episode explicitly addresses safety concerns, abuse risk, research challenges, and the importance of therapeutic context.
psilocybinMDMApharmacologydepression
Access and content notes
Access: Free — public Cleveland Clinic page with an online player and a link to the full show.
Discusses depression, PTSD, anxiety, substance-use risk, and medication safety; no graphic-content warning is posted.
Psychedelic Medicine Podcast — Managing Medical Risk in Patients Seeking Psilocybin Therapy with Reid Robison, MD, MBA
Psychedelic Medicine Podcast / Plant Medicine.org; host Lynn Marie Morski, MD, JD
Psychiatrist Reid Robison discusses how clinicians approach medical-risk assessment for psilocybin therapy, including pharmacokinetics, psychiatric medications, contraindications, and cardiovascular considerations. The episode treats guidance as evolving with evidence and highlights psychological risk alongside potential clinical uses.
Psychedelic Medicine Podcast — Is Psilocybin Safe for Me? with Seth Mehr, MD
Psychedelic Medicine Podcast / Plant Medicine.org; host Lynn Marie Morski, MD, JD
Emergency physician and licensed facilitator Seth Mehr outlines individualized safety planning for psilocybin therapy, covering medical conditions, medication combinations, mental-health history, contingency planning, and informed consent. It is a practical discussion of questions a prospective patient may raise with appropriately qualified care professionals, not a substitute for assessment.
Includes discussion of suicidal ideation, psychosis and bipolar-family history, seizures, substance-use disorders, medical emergencies, and psychological crisis.
The Psychedelic Podcast, Episode 362 — Psychedelic Preparation: Why Safety Starts in the Body
The Third Wave; host Paul F. Austin with Dave M. Rabin, MD, PhD
Paul F. Austin and psychiatrist-neuroscientist Dave Rabin discuss preparation through the lens of nervous-system regulation, trauma, consent, and the possibility that an experience may feel overwhelming or be difficult to integrate. The episode explores a preparation perspective that goes beyond set and setting while acknowledging touch and consent as safety-sensitive issues.
Michael Pollan (presenter) and Alex Gibney (executive producer)
This series uses history, reporting, and interviews to examine changing public and scientific approaches to LSD, psilocybin, MDMA, and mescaline. It places individual experiences alongside questions of research, law, and therapeutic practice.
psychedelic researchpsilocybinMDMAhistory and policy
Access and content notes
Access: Subscription — Netflix; catalogue availability varies by country.
TV-MA. Contains discussion of psychoactive-drug use, mental-health experiences, and potentially distressing personal accounts.
Films & documentariesTelevision documentary episode (53m 47s)
Can Psychedelics Cure?
NOVA / WGBH Educational Foundation
This NOVA episode surveys renewed scientific investigation of psychedelic compounds in relation to addiction, depression, and PTSD. It frames the subject through research history and contemporary clinical questions rather than as a guide to use.
clinical researchaddictiondepressionPTSD
Access and content notes
Access: Paid — the PBS streaming window has expired; the official page links to purchase options through Apple TV and Amazon.
TV-14. Includes discussion of mental illness, addiction, PTSD, and psychoactive substances.
Roslyn Dauber follows clinicians, researchers, and several participants as they discuss psilocybin research after restrictions on psychedelic studies began to ease. The film includes accounts connected with terminal illness, depression, trauma, and existential distress.
psilocybinclinical researchend-of-life distressmental health
Access and content notes
Access: Paid — commercial Apple TV listing; transaction availability and pricing may vary by region.
Unrated. Contains terminal-illness and end-of-life discussion, mental-health themes, and accounts of psychedelic sessions.
Filmmaker Monty Wates documents an early Imperial College London psilocybin study involving people with clinical depression. The film follows participants, relatives, and staff over several years and emphasizes the complexity of a supervised research protocol.
psilocybindepressionclinical trialspsychological support
Access and content notes
Access: Mixed — the official site promotes ticketed screenings; Prime Video offers account- and region-dependent viewing options.
18+ on the verified Prime Video listing; includes substance use, strong language, sexual content, depression, and flashing/strobing patterns.
Set around a Swiss experiment, this film considers what may be learned by combining meditation practice with a double-blind psilocybin study involving experienced Zen meditators. Its approach combines observational material with stylized animation and sound design to address consciousness research.
psilocybinmeditationconsciousness researchset and setting
Access and content notes
Access: Mixed — the official site lists Gaia streaming and paid Vimeo, Apple TV, and Prime Video options; availability varies by service and territory.
Contains depictions and discussion of psychedelic administration, altered states, and intense audiovisual effects that may be unsuitable for photosensitive viewers.
This documentary travels to the Amazon to consider ayahuasca within ceremonial and cultural contexts, alongside accounts from visitors seeking spiritual or personal change. It also raises the possible pitfalls of use rather than presenting the practice as risk-free.
ayahuascaAmazonian traditionsspiritualitysafety and risks
Access and content notes
Access: Subscription — Netflix; the verified page reports that the title is currently unavailable in its detected country, so access is region-dependent.
TV-PG. Contains ceremonial psychoactive-substance use and spiritual themes; ayahuasca can carry legal, cultural, and health considerations not resolved by the film.
Using observation and animation, this film follows three former Navy SEALs living with post-combat trauma as they travel to Mexico for psychedelic experiences. It focuses on their relationships and difficult aftermath as well as their search for relief.
veteranspost-combat traumapsychedelicsintegration and family
Access and content notes
Access: Subscription — now streaming on Netflix, according to the film’s official site; availability may vary by country.
Contains trauma, PTSD, war-related material, emotionally intense family situations, and psychedelic-session content.
Films & documentariesSeven-episode documentary series
Ibogaine: The Fight Of A Lifetime
Fox Nation
This Fox Nation series follows a veteran who travels across the border to seek ibogaine and examines a Texas policy campaign around its legal status. Supplementary episodes bring together accounts of combat trauma, addiction, advocacy, and current scientific questions.
ibogaineveteransaddictionpolicy and legality
Access and content notes
Access: Subscription — Fox Nation, with a free-trial offer advertised on the verified programme page.
TV-MA. Contains war trauma, mental-health struggles, addiction, and discussion of controlled-substance use.
This documentary follows a woman with depression, anxiety, and opioid addiction after conventional medications have not met her needs. It records her encounters with underground practitioners and illegal psilocybin- and iboga-related approaches, making clear that these occur outside standard legal care.
ibogainepsilocybinopioid addictionmental health
Access and content notes
Access: Paid — the filmmakers offer a 48-hour online viewing window for a pay-what-you-can contribution, with a stated preferred minimum of US$7.97.
Contains opioid addiction, anxiety, depression, illegal substance use, and potentially upsetting recovery scenes. The distributor states its content is educational and not medical advice.
Luc Côté follows two combat veterans and their families as they confront PTSD, medication experiences, and difficult attempts to readjust after war. Ayahuasca and other psychedelic experiences are presented as part of their personal narratives, including the challenges of family adjustment and integration.
veteransPTSDayahuascafamily integration
Access and content notes
Access: Paid — verified Prime Video options list HD rental for US$4.99 and purchase for US$9.99, subject to regional change.
R. Contains combat trauma, PTSD, anxiety, depression, family conflict, medication issues, and psychoactive-substance use.
With access to an Imperial College London study, this BBC film follows a controlled comparison of psilocybin with psychological support against an SSRI for clinical depression. It tracks researchers and 59 participants over 16 months, including immediate and longer-term participant perspectives.
psilocybinclinical trialdepressionsafety and psychological support
Access and content notes
Access: Free — BBC programme page, but the verified page states that the film is not currently available on BBC iPlayer.
Contains depression and mental-health discussion plus supervised psychedelic-session material. BBC notes that the use shown occurred in a controlled trial and that the substances are illegal in the UK and not available there as medical treatment.
This film introduces Taita Juanito Guillermo Chindoy Chindoy and follows visitors participating in an ayahuasca ceremony in the Colombian Amazon. Interviews with scholars and authors place the ceremony within discussions of Indigenous tradition, cultural meaning, and emerging mental-health research.
ayahuascaIndigenous traditionsceremonymental-health research
Access and content notes
Access: Paid — commercial Apple TV listing; transaction availability and pricing may vary by region.
Unrated. Contains ceremonial psychoactive-substance use, personal distress, and spiritual material; it does not substitute for medical, legal, or culturally informed guidance.
This science documentary connects personal accounts of opioid addiction with reporting on brain mechanisms and evidence-based responses. It frames addiction as a chronic health condition while examining the effects of prescription opioids, heroin, and fentanyl.
opioid use disorderaddiction neuroscienceoverdosetreatment
Access and content notes
Access: Mixed — streams through PBS.org and the PBS app where available; PBS also lists paid Apple TV and Amazon purchase options.
TV-14. Includes candid discussion of addiction, withdrawal, overdose, and bereavement; may be emotionally difficult.
A long-form investigation follows people affected by heroin and prescription-opioid use while placing the crisis in the context of U.S. drug policy. It contrasts criminal-justice and public-health approaches to substance use.
heroinopioid crisisdrug policypublic health
Access and content notes
Access: Mixed — PBS provides the official title page with a trailer and viewing options; full-program availability and any paid options may vary by location and service.
Contains personal accounts of substance use, addiction, overdose, crime, and loss; emotionally intense material.
FRONTLINE / PBS and the Financial Times; produced by Tom Jennings, Annie Wong, and Nick Verbitsky
This investigation examines the marketing and business practices of Insys Therapeutics surrounding a fentanyl-based pain medicine. It uses the company’s case to explore links among pharmaceutical promotion, prescribing, fraud allegations, and the opioid crisis.
Recovery documentariesTwo-part documentary series (2 episodes)
The Crime of the Century
HBO Documentary Films; directed by Alex Gibney
This two-part documentary investigates the development of the U.S. opioid crisis, with attention to OxyContin promotion, fentanyl, pharmaceutical companies, and policy decisions. It presents a journalistic account of institutional and commercial factors alongside the human consequences.
Federal Bureau of Investigation and Drug Enforcement Administration
This government-produced film uses first-person testimony and professional perspectives to discuss prescription-opioid and heroin addiction. It was made to help students and young adults recognize risks and consequences associated with opioid misuse.
This program brings together community experiences and expert commentary to explain how the opioid epidemic developed in the United States. It considers local impacts as well as possible directions for response and prevention.
opioid epidemiccommunity impactpreventionpublic health
Access and content notes
Access: Free — PBS lists the program as streamable on PBS.org and the PBS app; local broadcast availability may vary.
TV-PG. Discusses opioid addiction and its effects on individuals and communities, including overdose-related loss.
Recovery documentariesEducational television episode (26m 46s)
Addiction And The Brain
QED With Dr. B / WOSU Public Media
This concise science program reviews neurotransmitters involved in addiction and introduces evolving neuroscience perspectives on identifying and responding to it. Its emphasis is explanatory rather than autobiographical or investigative.
Recovery documentariesUniversity public-lecture special (57m 44s)
The Neuroscience of Addiction
University Place / PBS Wisconsin; presentation by Brenda del Moral of Edgewood College
In a public lecture, a biological sciences professor surveys addiction from whole-body and molecular perspectives. The session explains physiological processes and diagnostic concepts for a general learning audience.
Recovery documentariesSeven-part public educational video series (individual videos 11–18m)
Family Learning Series
Pennsylvania Department of Drug and Alcohol Programs
This seven-video government series is designed for families and friends supporting someone with a substance use disorder. It covers the condition, treatment and recovery processes, practical boundaries, support resources, and age-appropriate conversations with children.
substance use disorderfamily supporttreatment navigationrecovery
Access and content notes
Access: Free — the Commonwealth of Pennsylvania provides the full series on its public Department of Drug and Alcohol Programs page.
Addresses family disruption, overdose-reversal resources, recovery challenges, and children affected by parental substance use; potentially emotionally difficult.
Recovery documentariesPublic television episode (26m 46s)
Alcohol Sobriety & Education
Mutually Inclusive / WGVU Public Media
This local public-television episode features conversations with people in West Michigan’s sober community and identifies recovery-oriented resources. It explores alcohol addiction and sobriety through community perspectives rather than providing clinical instruction.
alcohol usesobrietyrecoverycommunity resources
Access and content notes
Access: Free — available to stream through PBS.org and the PBS app.
Includes personal discussion of alcohol addiction and recovery; may be sensitive for viewers affected by substance use. No specific maturity rating is listed.
Courses & guidesSelf-directed professional training
Training: Assessing and Addressing Opioid Use Disorder
Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control
This professional training covers DSM-5-based identification of opioid use disorder, patient-centered discussion of the diagnosis, and treatment approaches. CDC directs eligible health professionals to CDC TRAIN to obtain continuing-education credit after completing the course and evaluation.
opioid use disorderclinical assessmentpatient communicationtreatment
Access and content notes
Access: Free (public CDC landing page; free continuing education is available through CDC TRAIN registration).
Discusses opioid use disorder and treatment; no graphic material is indicated on the landing page.
Courses & guidesToolkit with modular training, cases, fact sheets, and conversation starters
Naloxone Toolkit
Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control
This toolkit organizes short and full learning modules on discussing naloxone, assessing overdose risk, and using non-stigmatizing communication. It also supplies case exercises and materials tailored to clinicians, pharmacists, health-system leaders, and families or caregivers.
Includes opioid-overdose recognition and response information, which some readers may find distressing; no graphic imagery is indicated on the landing page.
Courses & guidesClinical toolkit with primer, checklist, learning modules, and patient cases
Addiction Medicine Toolkit
Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control
This introductory clinical toolkit combines a substance-use-disorder primer and practice checklist with modules on assessment, treatment options, communication, and care coordination. Interactive cases let health professionals apply those concepts to treatment-related scenarios.
substance use disordersaddiction medicineclinical communicationcare coordination
Access and content notes
Access: Free (public CDC toolkit; free continuing education is available through CDC TRAIN after completion of all modules and evaluation).
Addresses substance use disorders, drug overdose, and treatment decisions; no graphic material is indicated on the landing page.
Courses & guidesPrevention learning program with downloadable guides, discussion tools, sessions, media, and a podcast
"Talk. They Hear You." Underage Drinking Campaign
Substance Abuse and Mental Health Services Administration (SAMHSA)
SAMHSA’s prevention program provides practical materials that help trusted adults begin and sustain age-appropriate conversations intended to prevent underage drinking and other substance use. Its public hub links to parent, educator, community, and school-oriented resources, including discussion guides and educational sessions.
National Fentanyl Prevention and Awareness Day™ Toolkit
Centers for Disease Control and Prevention (CDC)
This partner toolkit supplies ready-to-share prevention messaging, caregiver conversation prompts, sample social posts, and links to CDC materials on illicit fentanyl, counterfeit pills, naloxone, and overdose response. It is structured for organizations seeking to communicate with families, schools, and community partners around an awareness observance.
Explicitly discusses fatal overdoses, counterfeit pills, grief, and emergency response; this may be distressing. No graphic imagery is indicated on the landing page.
Courses & guidesTwo-lesson curriculum with videos, infographics, educator materials, and optional surveys
Aware & Prepare: A Comprehensive Curriculum for Fentanyl & Other Opioid Overdose Prevention and Harm Reduction
Stanford Medicine, Halpern-Felsher REACH Lab
This two-lesson curriculum explains opioids and fentanyl, their potential harms, overdose signs, and harm-reduction tools such as naloxone and test strips. The public page provides lessons and companion resources for educators, students, parents, and other community learners.
Access: Mixed (core online materials are publicly viewable; optional Canva-based editing and download features may depend on account type).
Includes discussions of drug overdose, overdose deaths, emergency response, and use of test strips; this may be distressing. No graphic imagery is indicated on the landing page.
Courses & guidesInteractive youth learning program with handouts and role-playing exercises
NIAAA for Middle School
National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health
This middle-school resource offers adult-led activities on alcohol, peer pressure, and resistance skills for learners ages 11–13. It includes background briefings, student handouts, and role-play scripts designed for home, classroom, or after-school use.
Courses & guidesProfessional guide and resource hub
Alcohol Screening and Brief Intervention for Youth: A Practitioner’s Guide
National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health
This practitioner resource hub supports youth alcohol screening and brief intervention by assembling screening tools, risk-assessment information, training links, motivational-interviewing resources, and referral materials. It also directs parents to public prevention publications and family-oriented resources.
Access: Free (public NIH guide and linked resource hub; some external linked tools may have their own access terms).
Addresses alcohol-related problems, substance-use screening, and referral for further evaluation; no graphic material is indicated on the landing page.
Research portalsPrimary clinical-trial registry search
ClinicalTrials.gov — Psilocybin Search
U.S. National Library of Medicine (NIH)
This searchable U.S. registry returns registered psilocybin studies and lets users examine study status, eligibility, outcomes, locations, sponsors, results, and selected documents. Registry listing does not establish a study’s safety, scientific quality, or suitability for clinical care.
psilocybinclinical trialsstudy resultsrecruitment
Access and content notes
Access: Free public access; no account is required to search or view records.
May describe psychoactive-substance exposure, psychiatric conditions, substance use, eligibility restrictions, and adverse events.
Research portalsUniversity evidence and trial-discovery portal
Clinical Trials Map
UC Berkeley Center for the Science of Psychedelics
This map and list interface repackages ClinicalTrials.gov data for past, ongoing, and future studies involving substances such as psilocybin, MDMA, DMT, and 5-MeO-DMT. Filters support comparison by substance, status, phase, demographics, and study documents, with links back to full registry records.
psychedelic clinical trialspsilocybinMDMADMT
Access and content notes
Access: Free public access; no account is required.
May reference psychoactive substances, depression, PTSD, substance-use disorders, and research participation criteria.
Research portalsInteractive policy map and legislative evidence portal
Psychedelic Law and Policy Map
UC Berkeley Center for the Science of Psychedelics, with Psychedelic Alpha, Calyx Law, and Antithesis Law
This state-by-state map tracks enacted, pending, and inactive U.S. measures concerning psychedelic research, regulated access, and local reform, with linked source material and dated policy notes. It is a legal-information resource rather than a guide to obtaining or using substances.
Research portalsOfficial public-health evidence resource
Psilocybin for Mental Health and Addiction: What You Need To Know
National Center for Complementary and Integrative Health (NIH)
NCCIH summarizes research findings, study limitations, federal legal context, and safety considerations related to psilocybin and mental health or addiction research. It distinguishes early evidence from settled clinical guidance and directs readers not to delay appropriate health care.
psilocybinmental healthaddictionevidence review
Access and content notes
Access: Free public access; no account is required.
Contains discussion of hallucinations, anxiety, paranoia, psychosis, overdose or poisoning risk, addiction, and mental-health conditions.
Research portalsOfficial public-health and regulatory resource portal
Oregon Psilocybin Services
Oregon Health Authority, Public Health Division
The Oregon Health Authority’s portal documents the state-administered licensing and regulatory framework for psilocybin products and services, along with data, reports, rules, public meetings, and licensee information. It describes a state program and should not be read as a medical recommendation or a substitute for individualized care.
psilocybin servicespublic health regulationlicensingservice-center data
Access and content notes
Access: Free public access; no account is required for the portal and listed reports.
Addresses a psychoactive controlled substance, service access, regulation, complaints, and mental-health crisis support.
Research portalsOfficial medicines-regulation and public-health resource hub
MDMA and Psilocybine Hub
Therapeutic Goods Administration, Australian Government
This Australian regulator’s hub consolidates consumer, psychiatrist, pharmacy, manufacturer, quality, and access information for MDMA and psilocybine under the Authorised Prescriber scheme. It identifies the limited conditions and professional authorization pathways addressed by the regulator without presenting the information as a general treatment recommendation.
MDMApsilocybintreatment-resistant depressionPTSD
Access and content notes
Access: Free public access; no account is required.
Research portalsInternational clinical-trial evidence portal
WHO ICTRP Clinical Trials Search Portal
World Health Organization
WHO’s portal aggregates registration datasets from multiple recognized trial registries, links related records, and directs users to original records; searching terms such as psilocybin or MDMA can identify relevant registered studies across jurisdictions. WHO states that records are provided as a service and are not endorsements or clinical-care advice.
international clinical trialspsilocybinMDMAtrial registration
Access and content notes
Access: Free public access; no account is required for searching or record export.
May include studies of psychoactive substances, psychiatric diagnoses, substance-use conditions, and trial interventions; registry records are not clinical advice.
Research portalsUniversity research-publications portal
Published Studies
Johns Hopkins Center for Psychedelic and Consciousness Research
This Johns Hopkins collection indexes publications associated with the center and links to journal-hosted research on psychedelic pharmacology, clinical studies, safety, ethics, mechanisms, and policy. The bibliography is free to browse, while availability of individual full-text articles depends on the linked journal or publisher.
psychedelic sciencepsilocybinDMTMDMA
Access and content notes
Access: Mixed: the publication index is free, but linked full articles may be open access, abstract-only, or require a subscription or purchase.
Publication titles and linked studies may discuss psychiatric illness, addiction, altered perception, adverse effects, and other sensitive health topics.